Results 341 to 350 of about 835,082 (382)
Some of the next articles are maybe not open access.
Seminars in Neurology, 2001
Dopamine agonists provide an effective means of treating early, middle, and late stages of Parkinson's disease. This article outlines the advantages and disadvantages of dopamine agonists as compared with levodopa therapy. The features and costs of the four Food and Drug Administration-approved agonists (bromocriptine, pergolide, pramipexole, and ...
P, Tuite, B, Ebbitt
openaire +2 more sources
Dopamine agonists provide an effective means of treating early, middle, and late stages of Parkinson's disease. This article outlines the advantages and disadvantages of dopamine agonists as compared with levodopa therapy. The features and costs of the four Food and Drug Administration-approved agonists (bromocriptine, pergolide, pramipexole, and ...
P, Tuite, B, Ebbitt
openaire +2 more sources
Clinical Science, 1982
It would seem established beyond peradventure that dopamine is formed in the kidney from circulating L-dopa. The likely site would appear to be the renal tubular cells but the contribution of the renal dopaminergic nerves needs further evaluation. Moreover it is probably that dopamine formed within the kidney acts there on specific receptors.
openaire +2 more sources
It would seem established beyond peradventure that dopamine is formed in the kidney from circulating L-dopa. The likely site would appear to be the renal tubular cells but the contribution of the renal dopaminergic nerves needs further evaluation. Moreover it is probably that dopamine formed within the kidney acts there on specific receptors.
openaire +2 more sources
Dopamine turnover estimated by simultaneous LCEC assay of dopamine and dopamine metabolites
Journal of Pharmacological Methods, 1982The estimation of changes in tissue levels of dopamine (DA) and its metabolites has been employed to approximate the turnover rate or release of DA. We have developed an assay using high pressure liquid chromatography with electrochemical detection to quantify DA, dihydroxyphenylacetic acid (DOPAC), 3-methoxytyramine (3-MT), and homovanillic acid (HVA)
C H, Cheng, G F, Wooten
openaire +2 more sources
American Journal of Health-System Pharmacy, 2008
Lertxundi et al.[1][1] should be commended for reminding readers of the therapeutic complexities in using antidopaminergic agents in Parkinson’s disease (PD). We wish to comment on the etiology and treatment of hiccups.
Anka, Stegmeier-Petroianu +1 more
openaire +2 more sources
Lertxundi et al.[1][1] should be commended for reminding readers of the therapeutic complexities in using antidopaminergic agents in Parkinson’s disease (PD). We wish to comment on the etiology and treatment of hiccups.
Anka, Stegmeier-Petroianu +1 more
openaire +2 more sources
Journal of the American Geriatrics Society, 1978
ABSTRACT: Regardless of the age of the patient, dopamine is a valuable agent for treating shock associated with an abdominal catastrophe. However, when the time is appropriate for withdrawal of dopamine, the aged do not react as do younger patients. Despite apparent adequate hydration, additional volume loading is required to avert renal failure, and ...
J S, Freed, A, Kaynan, P H, Szuchmacher
openaire +2 more sources
ABSTRACT: Regardless of the age of the patient, dopamine is a valuable agent for treating shock associated with an abdominal catastrophe. However, when the time is appropriate for withdrawal of dopamine, the aged do not react as do younger patients. Despite apparent adequate hydration, additional volume loading is required to avert renal failure, and ...
J S, Freed, A, Kaynan, P H, Szuchmacher
openaire +2 more sources
Medical Clinics of North America, 1999
Dopamine agonists have been used in the treatment of Parkinson's disease (PD) since the mid 1970s. With the approval of two new agents in 1997, the number available in the United States is up to four; bromocriptine, pergolide, pramipexole, ropinirole.
openaire +2 more sources
Dopamine agonists have been used in the treatment of Parkinson's disease (PD) since the mid 1970s. With the approval of two new agents in 1997, the number available in the United States is up to four; bromocriptine, pergolide, pramipexole, ropinirole.
openaire +2 more sources
Annals of Internal Medicine, 1977
Excerpt To the editor: In the recent paper by Huseby and Hudson (Ann Intern Med85:609-611, 1976) discussing adult respiratory distress syndrome in patients with miliary tuberculosis, one of their p...
S L, Barriere, L D, Hudson, J S, Huseby
openaire +2 more sources
Excerpt To the editor: In the recent paper by Huseby and Hudson (Ann Intern Med85:609-611, 1976) discussing adult respiratory distress syndrome in patients with miliary tuberculosis, one of their p...
S L, Barriere, L D, Hudson, J S, Huseby
openaire +2 more sources
Science, 1997
Ingrid Wickelgren's Special News Report “Getting the brain's attention” ([3 Oct., p. 35][1]) presents the views of those who question the current orthodoxy that dopamine acts in the nucleus accumbens as a key neurotransmitter underlying the behavioral effects of positive reinforcement or ...
J A, Gray, A M, Young, M H, Joseph
openaire +2 more sources
Ingrid Wickelgren's Special News Report “Getting the brain's attention” ([3 Oct., p. 35][1]) presents the views of those who question the current orthodoxy that dopamine acts in the nucleus accumbens as a key neurotransmitter underlying the behavioral effects of positive reinforcement or ...
J A, Gray, A M, Young, M H, Joseph
openaire +2 more sources
Brain Research, 2006
Social attachments play a central role in human society. In fact, such attachments are so important that deficits in the ability to form meaningful social bonds are associated with a variety of psychological disorders. Although mother-infant bonding has been studied for many years, we only recently have begun to examine the processes that underlie ...
J Thomas, Curtis +3 more
openaire +2 more sources
Social attachments play a central role in human society. In fact, such attachments are so important that deficits in the ability to form meaningful social bonds are associated with a variety of psychological disorders. Although mother-infant bonding has been studied for many years, we only recently have begun to examine the processes that underlie ...
J Thomas, Curtis +3 more
openaire +2 more sources
Neurology, 1998
To the Editor: We read with interest the review by Peroutka on dopamine and migraine.1 The author concluded that an increased dopaminergic activity is a key pathophysiologic component of migraine. However, some points are debatable. We agree on the existence of a dopaminergic hypersensitivity in migraine.
P. Barbanti +2 more
openaire +2 more sources
To the Editor: We read with interest the review by Peroutka on dopamine and migraine.1 The author concluded that an increased dopaminergic activity is a key pathophysiologic component of migraine. However, some points are debatable. We agree on the existence of a dopaminergic hypersensitivity in migraine.
P. Barbanti +2 more
openaire +2 more sources